Cubicin(R) for Complicated Post-surgical Wound Infections

Trial Profile

Cubicin(R) for Complicated Post-surgical Wound Infections

Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Daptomycin (Primary)
  • Indications Gram-positive infections; Postoperative infections; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Sponsors Cubist Pharmaceuticals
  • Most Recent Events

    • 23 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top